Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that certain male pattern baldness subtypes at age 45 are associated with an increased risk of developing colorectal neoplasia.

This study found that applying a mix of cholesterol and Tween 60 detergent to mouse skin significantly reduced epidermal cell mitotic activity.

This study found that 32% of men continued finasteride use for 1 to 3 years, with many reporting poor hair growth results.

This study reviewed 26 cases of X-linked recessive ichthyosis and observed 11 patients with advanced-stage androgenetic alopecia, suggesting a compensatory role of two steroid biosynthesis pathways.

In this study, researchers identified over 250 new genetic loci linked to severe male pattern baldness, and developed a prediction algorithm that could accurately differentiate between those with severe and no hair loss.

This study identified that higher trait anxiety, appearance orientation, and private self-consciousness are among the key predictors of future anxiety about male pattern baldness in young men.

A trial found that using finasteride, a hair growth drug, can be effectively measured by comparing before and after photos.

This study found no significant genetic correlations between male pattern baldness and COVID-19 outcomes, suggesting that shared genetic factors may not explain the reported association.

This case report details a woman with autoimmune primary ovarian insufficiency linked to hormonal contraception discontinuation, who achieved pregnancy through ovarian stimulation and in vitro fertilization despite typically low fertility in such conditions.

This study found that higher cumulative doses of topical minoxidil solution were strongly associated with improved hair density and thickness in male patients with androgenic alopecia over a 24-week period.

This study found no significant hair growth difference between men treated with polysorbate 60 and those given a placebo, suggesting its ineffectiveness for male pattern baldness.

This study evaluated shaved style scalp medical tattoo (SMT) in individuals with advanced hair loss, reporting high patient and surgeon satisfaction scores.

This review discusses the mechanisms of androgenic alopecia and reports no new results; the development of a mouse model for further study is described.

Keith Kaufman reported promising results on treating male-pattern baldness with oral finasteride at the World Congress of Dermatology.

This meta-analysis suggests that any pattern of male baldness may be associated with a decreased risk of testicular cancer, with stage II hair loss providing the strongest protective effect.

This commentary discusses how common latent viruses might contribute to male-pattern baldness through mechanisms involving transcription factor deficiency and overexpression of specific proteins, based on a concept called microcompetition; it reports no new research results.

This article reviews depictions of baldness in art and notes its symbolic connections to depression, with no new research findings presented.

This review examines current medical and surgical treatments for androgenetic alopecia, including medications like minoxidil and advancements in hair transplantation techniques, without providing new clinical findings.

This review discusses the classification of female androgenic alopecia using the Ludwig classification and details the hair growth cycle but provides no new clinical results.

This study in Chinese patients with male pattern baldness found that 2% minoxidil solution led to moderate hair growth in 22% of participants and was generally well-tolerated.

2% topical minoxidil can help reduce hair loss and promote hair growth in male pattern baldness.

This review examined a polyherbal hair formulation aimed at managing male pattern baldness, reporting that its ingredients may enhance scalp blood circulation, strengthen hair follicles, and promote hair regrowth through various mechanisms such as antioxidant and DHT-inhibiting effects.

This review examines a polyherbal hair oil formulation containing ingredients like Amla and Pumpkin seed oil, reporting potential benefits for managing male pattern baldness through antioxidant, anti-inflammatory, and DHT-inhibiting properties, alongside improved scalp blood circulation and hair regrowth.

This review reports on a polyherbal hair formulation developed to manage male pattern baldness, highlighting its potential to enhance scalp blood circulation, strengthen hair follicles, and promote hair regrowth through antioxidant, anti-inflammatory, and DHT-inhibiting mechanisms.

This study reviews the use of natural products, like herbal extracts and essential oils, in treating male pattern baldness, noting their potential benefits compared to conventional therapies that may carry side effects or ethical concerns.

This review highlights a polyherbal hair formulation that combines various natural ingredients, reporting potential benefits in improving scalp circulation, strengthening hair, and promoting regrowth, which might offer a safer alternative for managing male pattern baldness compared to synthetic drugs.

Minoxidil and finasteride are recommended for male pattern baldness.

Minoxidil and finasteride are recommended for male pattern baldness.

In this case report, a 27-year-old woman with female pattern baldness experienced reduced hair fall and improved hair density after six months of individualized homeopathic treatment, supported by lifestyle guidance at Dr Batra’s® Homeopathy Clinic, with sustained benefits observed over an additional eight-month follow-up period.

In this case report, long-term classical homeopathic management of a woman with advanced female pattern baldness led to significant hair stabilization, improved scalp health, increased hair density, and notable psychosocial benefits, despite previous treatment failures.